Lupkynis

Active Ingredient(s): Voclosporin
FDA Approved: * January 22, 2021
Pharm Company: * AURINIA
Category: Immunosuppressive

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Lupkynis Overview

Voclosporin, sold under the brand name Lupkynis, is a calcineurin inhibitor used as an immunosuppressant medication. It was approved by the U.S. Food and Drug Administration (FDA) for the treatment of lupus nephritis (LN) on January 22, 2021.[1][2][3] It is an analog of ciclosporin that has enhanced action against calcineurin and greater metabolic stability.[4] Voclosporin was discovered by Robert T. Foster and his team at Isote...

Read more Lupkynis Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Voclosporin

Recent Lupkynis Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Voclosporin
  • Capsule: 7.9mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Voclosporin or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA